Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ACTAVIS INC
2014 Ackman supports Allergan's $66 billion sale to Actavis
2014DJAstraZeneca Bets Long Term on Cancer Drugs -- 2nd Update
2014DJActavis Outlines Allergan Breakup Fee, Board Appointments
2014DJDeal Boom Feeds on Surging Stocks
2014DJActavis To Buy Allergan In $66 Billion Deal -- 5th Update
2014DJMARKET SNAPSHOT : S&P 500 Registers 42nd Record Close In Skittish Market
2014DJStocks Close Higher, With S&P Hitting Another Record High
2014DJMARKET SNAPSHOT : S&P 500 Registers 42nd Record Close In Skittish Market
2014DJActavis To Buy Allergan in $66 Billion Deal -- 5th Update
2014DJU.S. Stocks Higher in Late Trade
2014DJMARKET SNAPSHOT : S&P 500 Struggles Toward Record Close In Choppy Trade
2014DJMARKET SNAPSHOT : S&P 500 Struggles Toward Record Close In Choppy Trade
2014DJMARKET SNAPSHOT : S&P 500 Struggles Toward Record Close In Choppy Trade
2014DJAckman, Valeant Can't Justify Topping Actavis Bid for Allergan
2014 Allergan agrees to $66 bln Actavis offer; Valeant walks
2014 Allergan agrees to $66 billion Actavis offer; Valeant walks
2014DJU.S. Stocks Edge Higher in Afternoon Trade
2014 Losing Allergan deals blow to Valeant reputation
2014DJMARKET SNAPSHOT : S&P 500 Struggles Toward Record Close In Choppy Trade
2014DJU.S. Stocks Mixed in Afternoon Trade
2014DJMARKET SNAPSHOT : U.S. Stocks Edge Lower; Baker Hughes Surges
2014 Valeant says can't justify matching Actavis bid for Allergan
2014DJMARKET SNAPSHOT : U.S. Stocks Edge Lower; Baker Hughes Surges
2014DJActavis To Buy Allergan In $66 Billion Deal--4th Update
2014DJActavis To Buy Allergan In $66 Billion Deal--3rd Update
2014DJActavis To Buy Allergan In $66 Billion Deal--2nd Update
2014DJActavis To Buy Allergan In $66 Billion Deal--Update
2014DJMARKET SNAPSHOT : U.S. Stocks: Futures Lower; Industrial Production Next
2014DJMARKET SNAPSHOT : U.S. Stocks: Futures Lower After Japan Falls Into Recession
2014DJMARKET SNAPSHOT : U.S. Stocks: Futures Lower After Japan Falls Into Recession
2014DJAllergan, Actavis Near Deal -- 3rd Update
2014 WILLIAM ACKMAN : Allergan near buyout of up to $65 billion to escape Valeant, Ac..
2014DJAllergan, Actavis Near Deal -- 2nd Update
2014 AstraZeneca not only game in town for deal-hungry Pfizer
2014 ACTAVIS : Announces FDA Acceptance of sNDA for SAPHRIS® (asenapine) for the Trea..
2014 TSX rises as energy shares lead broad advance
2014 Actavis may buy Allergan for at least $60 billion - Bloomberg
2014 ACTAVIS : Names Maria Teresa Hilado Chief Financial Officer
2014 Allergan in discussions with another party after approach
2014 ACTAVIS : Announces Planned Retirement of R. Todd Joyce in Early 2015
2014 Allergan says has been approached by another party about a deal
2014DJMARKET SNAPSHOT : Media, Consumer-based Company Earnings To Test Stock Rally
2014 ACTAVIS : Financial Results, Acquisition Agreement, and Legal Issue Update - Res..
2014DJPfizer Results Will Play Second Fiddle to Dealmaking Outlook -- Earnings Prev..
2014 ACTAVIS : Confirms Appeals Court Upholds Lo Loestrin® Fe Patent
2014 ACTAVIS : Signs Option to Acquire Rhythm Subsidiary and its GI Development Produ..
2014 ACTAVIS : Signs Option to Acquire Rhythm Subsidiary and its GI Development Produ..
2014 Actavis, Sanofi among bidders for Omega Pharma- Bloomberg
2014 Top Allergan holder Paulson urges deal with Shire - sources
2014 TOP ALLERGAN HOLDER PAULSON URGES DE : sources
2014 ACTAVIS : Confirms Generic Quillivant XR® Patent Challenge
2014 EXCLUSIVE - TOP ACTAVIS HOLDER, FIDE : sources
2014 Allergan raises outlook; says Valeant offer undervalues company
2014 ACTAVIS : Ironwood and Actavis to Present Linaclotide Data at the American Colle..
2014 EXCLUSIVE : Actavis plans new merger approach for Allergan - sources
2014 EXCLUSIVE - ACTAVIS PLANS NEW MERGER : sources
2014 ACTAVIS : INVESTOR ALERT: The Law Offices of Vincent Wong Investigates the Board..
2014 ACTAVIS : INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Bo..
2014 Wall St. falls in choppy day; traders wary before earnings
2014 ACTAVIS : DURATA THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. An..
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 ACTAVIS : to Host Third Quarter 2014 Earnings Conference Call and Webcast
2014DJAllergan Reiterates Opposition to Valeant Bid
2014 ACTAVIS : Confirms Generic Butrans® Patent Challenge
2014DJDOW INDEX OVERSEERS MAKE IT OFFICIAL : U.S. Firms Only
2014 ACTAVIS IN BUYOUT TALKS WITH SALIX : Cnbc
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 Pfizer approaches Actavis to gauge interest in deal - Bloomberg
2014DJPfizer Has Contacted Actavis About Potential Deal, Parties Not In Formal Talk..
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 ACTAVIS : FDA Advisory Committee Recommends Against Approval of Actavis' Nebivol..
2014 ACTAVIS : Announces FDA Acceptance of the NDA Filing for Ceftazidime-Avibactam, ..
2014 ACTAVIS : Announces FDA Acceptance for Filing of NDA for Eluxadoline
2014 ACTAVIS : to Present at Morgan Stanley Global Healthcare Conference 2014
2014 ACTAVIS : Confirms Generic Neupro® Patent Challenge
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF